Efficacy and safety of re-induction regimen of decitabine combined with CAG in treatment of acute my- eloid leukemia after failed standard induction chemotherapy in the first course

CHEN Yili; ZHAO Wenshu; GUO Xutao; ZHAO Ke; ZHANG Yu; LIU Qifa; DAI Min

doi:10.3969/j.issn.1006-5725.2021.14.005

Home>Articles>Efficacy and safety of re-induction regimen of decitabine combined with CAG in treatment of acute my- eloid leukemia after failed standard induction chemotherapy in the first course

DOI: 10.3969/j.issn.1006-5725.2021.14.005

Efficacy and safety of re-induction regimen of decitabine combined with CAG in treatment of acute my- eloid leukemia after failed standard induction chemotherapy in the first course

CHEN Yili

ZHAO Wenshu

GUO Xutao

ZHAO Ke

ZHANG Yu

LIU Qifa

DAI Min

Machine-generated Keywords：

Publication Date：2021-07-25

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 1800-1804 )

The Journal of Practical Medicine

ISTICPKU

ISSN：1006-5725

Year, Vol.(Issue)：2021,37(14)